Apolipoprotein A5 Gene Variants and the Risk of Coronary Heart Disease: a Case‑control Study and Meta‑analysis

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2013 Aug 24

PMID 23970179

Citations 19

Authors

Jianqing Zhou

Limin Xu

Rong Stephanie Huang

Yi Huang

Yanping Le

Danjie Jiang

Xi Yang

Weifeng Xu

Xiaoyan Huang

Changzheng Dong

Meng Ye

Jiangfang Lian

Shiwei Duan

Affiliations

Soon will be listed here.

Abstract

Previous studies have shown that apolipoprotein A5 (APOA5) gene variants are genetic determinants of the concentration of triglycerides, which are a known risk factor for coronary heart disease (CHD). Using the standardized coronary angiography method, 290 CHD patients and 198 non‑CHD controls were recruited from Ningbo Lihuili Hospital. In addition, 331 unrelated healthy volunteers were recruited as healthy controls from Ningbo Ximen Community residents. Three variants of the APOA5 gene, S19W, ‑1131T>C and 553G>T, were analyzed for their association with CHD. Under a dominant inheritance model, ‑1131CT>C was shown to be a CHD risk factor (P=0.030; OR, 1.422; 95% CI, 1.036‑1.952). The single nucleotide polymorphism, 553G>T, was found to correlate with the severity of CHD in males (P=0.032). Meta‑analysis showed that ‑1131T>C was significantly associated with CHD (P<0.0001). By contrast, negative correlations with CHD were observed for S19W and 553G>T. In the present case‑control study, APOA5 gene variants were not found to correlate with the risk of CHD in the populations studied; however, ‑1131CT>C was shown to be a CHD risk factor under a dominant inheritance model. Meta‑analysis showed a significant contribution of ‑1131T>C to the risk of CHD, implying an ethnic difference in APOA5 gene variants.

Citing Articles

Genetic Polymorphisms and Genetic Risk Scores Contribute to the Risk of Coronary Artery Disease (CAD) in a North Indian Population.

Mastana S, Halai K, Akam L, Hunter D, Singh P Int J Mol Sci. 2024; 25(15).

PMID: 39126122 PMC: 11313018. DOI: 10.3390/ijms25158552.

Understanding Hypertriglyceridemia: Integrating Genetic Insights.

Alves M, Laranjeira F, Correia-da-Silva G Genes (Basel). 2024; 15(2).

PMID: 38397180 PMC: 10887881. DOI: 10.3390/genes15020190.

Transforming Medical Paradigms: A Cutting-Edge Review of Genomic and Robotic Medical and Surgical Approaches in the Battle Against Diabetes, Hypertension, and Cardiovascular Issues.

Tanveer Y, Sanipini S, Khleif R, Tsenteradze T, Gapizov A, Grezenko H Cureus. 2023; 15(10):e46998.

PMID: 37965396 PMC: 10641027. DOI: 10.7759/cureus.46998.

Apolipoprotein A5 gene polymorphism (rs662799) and cardiovascular disease in end-stage kidney disease patients.

Jacob J, Boczkowska S, Zaluska W, Buraczynska M BMC Nephrol. 2022; 23(1):307.

PMID: 36071387 PMC: 9450442. DOI: 10.1186/s12882-022-02925-1.

Coronary Artery Disease: Association Study of 5 Loci with Angiographic Indices of Disease Severity.

Bogari N, Allam R, Bouazzaoui A, Elkhateeb O, Porqueddu M, Colombo G Dis Markers. 2021; 2021:5522539.

PMID: 34336004 PMC: 8292076. DOI: 10.1155/2021/5522539.

References

Peden J, Farrall M . Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour. Hum Mol Genet. 2011; 20(R2):R198-205. PMC: 3179381. DOI: 10.1093/hmg/ddr384. View

Tang Y, Sun P, Guo D, Ferro A, Ji Y, Chen Q . A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis. 2005; 185(2):433-7. DOI: 10.1016/j.atherosclerosis.2005.06.026. View

Dallongeville J, Cottel D, Montaye M, Codron V, Amouyel P, Helbecque N . Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Int J Cardiol. 2005; 106(2):152-6. DOI: 10.1016/j.ijcard.2004.10.065. View

Pennacchio L, Olivier M, Hubacek J, Cohen J, Cox D, Fruchart J . An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001; 294(5540):169-73. DOI: 10.1126/science.1064852. View

Yuan S, Ma Y, Xie X, Yang Y, Fu Z, Ma X . [Association between apolipoprotein A5 gene polymorphism and coronary heart disease in the Han population from Xinjiang]. Zhonghua Liu Xing Bing Xue Za Zhi. 2011; 32(1):51-4. View

Yuan S, Ma Y, Xie X, Yang Y, Fu Z, Ma X . [Association of apolipoprotein A5 gene polymorphism with coronary heart disease in Uygur population of Xinjiang]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011; 28(1):73-7. DOI: 10.3760/cma.j.issn.1003-9406.2011.01.017. View

Excoffier L, Lischer H . Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour. 2011; 10(3):564-7. DOI: 10.1111/j.1755-0998.2010.02847.x. View

Kao J, Wen H, Chien K, Hsu H, Lin S . A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet. 2003; 12(19):2533-9. DOI: 10.1093/hmg/ddg255. View

Havasi V, Szolnoki Z, Talian G, Bene J, Komlosi K, Maasz A . Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke. J Mol Neurosci. 2006; 29(2):177-83. DOI: 10.1385/JMN:29:2:177. View

10.

Ramakrishnan L, Sachdev H, Sharma M, Abraham R, Prakash S, Gupta D . Relationship of APOA5, PPARγ and HL gene variants with serial changes in childhood body mass index and coronary artery disease risk factors in young adulthood. Lipids Health Dis. 2011; 10:68. PMC: 3120674. DOI: 10.1186/1476-511X-10-68. View

11.

Evans D, Aberle J, Beil F . Resequencing the apolipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia. Atherosclerosis. 2011; 219(2):715-20. DOI: 10.1016/j.atherosclerosis.2011.09.030. View

12.

Hubacek J, Wang W, Skodova Z, Adamkova V, Vrablik M, Horinek A . APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels. Clin Chem Lab Med. 2008; 46(6):773-7. DOI: 10.1515/CCLM.2008.160. View

13.

Lai C, Tai E, Tan C, Cutter J, Chew S, Zhu Y . The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res. 2003; 44(12):2365-73. DOI: 10.1194/jlr.M300251-JLR200. View

14.

Ruiz-Narvaez E, Yang Y, Nakanishi Y, Kirchdorfer J, Campos H . APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica. J Lipid Res. 2005; 46(12):2605-13. DOI: 10.1194/jlr.M500040-JLR200. View

15.

Dorfmeister B, Zeng W, Dichlberger A, Nilsson S, Schaap F, Hubacek J . Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding. Arterioscler Thromb Vasc Biol. 2008; 28(10):1866-71. DOI: 10.1161/ATVBAHA.108.172866. View

16.

Szalai C, Keszei M, Duba J, Prohaszka Z, Kozma G, Csaszar A . Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis. 2004; 173(1):109-14. DOI: 10.1016/j.atherosclerosis.2003.12.003. View

17.

Sarwar N, Sandhu M, Ricketts S, Butterworth A, Di Angelantonio E, Boekholdt S . Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet. 2010; 375(9726):1634-9. PMC: 2867029. DOI: 10.1016/S0140-6736(10)60545-4. View

18.

Maasz A, Kisfali P, Jaromi L, Horvatovich K, Szolnoki Z, Csongei V . Apolipoprotein A5 gene IVS3+G476A allelic variant confers susceptibility for development of ischemic stroke. Circ J. 2008; 72(7):1065-70. DOI: 10.1253/circj.72.1065. View

19.

Jang Y, Paik J, Hyun Y, Chae J, Kim J, Choi J . The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. Clin Chim Acta. 2009; 402(1-2):83-7. PMC: 4428346. DOI: 10.1016/j.cca.2008.12.024. View

20.

Liu H, Wang C, Zhang S, Xiao C, Li X, Zhang K . [Association of APOA5 gene single nucleotide polymorphism with levels of lipids and coronary heart disease in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004; 21(4):335-8. View